Health-related Quality of Life Instrument With 8 Items for Use in Patients With Type 2 Diabetes Mellitus: A Validation Study in Korea
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Objectives: This study assessed the validity and reliability of the Health-related Quality of Life Instrument with 8 Items (HINT-8) in patients with diabetes. HINT-8 is a newly-developed, generic health-related quality of life (HRQoL) instrument. Methods: Three HRQoL instruments—HINT-8, EuroQoL 5-Dimension 5-Level (EQ-5D-5L), and Short Form Health Survey version 2.0 (SF-36v2)—were provided to 300 patients with diabetes visiting a tertiary hospital for follow-up visits in Korea. The HRQoL scores obtained using the HINT-8 were evaluated for subgroups with known differences based on demographics and diabetes-related characteristics (known-group validity). The mean scores of the instruments were compared between groups segmented by their responses to the HINT-8 (discriminatory ability). Correlation coefficients of the HINT-8 with other instruments were calculated (convergent and divergent validity). The Cohen kappa and intra-class correlation coefficient (ICC) were also evaluated (test-retest reliability). Results: The average HINT-8 indexes were lower among women, older, and less-educated subjects. Subjects who did not list any problems on the HINT-8 had significantly higher HRQoL scores than those who did. The correlation coefficients of the HINT-8 with the EQ-5D-5L index and EuroQoL visual analogue scale were 0.715 (p<0.001) and 0.517 (p<0.001), respectively. The correlation coefficients between the HINT-8 index and the scores of 8 domains of the SF-36v2 ranged from 0.478 (p<0.001) to 0.669 (p<0.001). The Cohen kappa values for the HINT-8 ranged from 0.268 to 0.601, and the ICC of the HINT-8 index was 0.800 (95% confidence interval [CI], 0.720 to 0.860).
Abstract
Objectives: This study assessed the validity and reliability of the Health-related Quality of Life Instrument with 8 Items (HINT-8) in patients with diabetes. HINT-8 is a newly-developed, generic health-related quality of life (HRQoL) instrument. Methods: Three HRQoL instruments—HINT-8, EuroQoL 5-Dimension 5-Level (EQ-5D-5L), and Short Form Health Survey version 2.0 (SF-36v2)—were provided to 300 patients with diabetes visiting a tertiary hospital for follow-up visits in Korea. The HRQoL scores obtained using the HINT-8 were evaluated for subgroups with known differences based on demographics and diabetes-related characteristics (known-group validity). The mean scores of the instruments were compared between groups segmented by their responses to the HINT-8 (discriminatory ability). Correlation coefficients of the HINT-8 with other instruments were calculated (convergent and divergent validity). The Cohen kappa and intra-class correlation coefficient (ICC) were also evaluated (test-retest reliability). Results: The average HINT-8 indexes were lower among women, older, and less-educated subjects. Subjects who did not list any problems on the HINT-8 had significantly higher HRQoL scores than those who did. The correlation coefficients of the HINT-8 with the EQ-5D-5L index and EuroQoL visual analogue scale were 0.715 (p<0.001) and 0.517 (p<0.001), respectively. The correlation coefficients between the HINT-8 index and the scores of 8 domains of the SF-36v2 ranged from 0.478 (p<0.001) to 0.669 (p<0.001). The Cohen kappa values for the HINT-8 ranged from 0.268 to 0.601, and the ICC of the HINT-8 index was 0.800 (95% confidence interval [CI], 0.720 to 0.860).
참고문헌 (40)
- Cho NH, "Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045", Diabetes Res Clin Pract, 138, pp.271~281 (2018)
- Harding JL, "Global trends in diabetes complications : a review of current evidence", Diabetologia, 62(1), pp.3~16 (2019)
- Forssas E, "Multiple complications among people with diabetes from Finland : an 18-year follow-up in 1994-2011", BMJ Open Diabetes Res Care, 4(1), pp.e000254~ (2016)
- 원종철, "Diabetes Fact Sheet in Korea, 2016: An Appraisal of Current Status", Diabetes and Metabolism Journal, 42(5), pp.415~424 (2018), 대한당뇨병학회[DOI]
- Lee JW, "Trends in diabetes prevalence among Korean adults based on Korean National Health and Nutrition Examination Surveys III-VI", Diabetes Res Clin Pract, 138, pp.57~65 (2018)
- 김경진, "Ten-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013", Diabetes and Metabolism Journal, 42(5), pp.394~401 (2018), 대한당뇨병학회[DOI]
- Karimi M, "Health, health-related quality of life, and quality of life: what is the difference?", Pharmacoeconomics, 34(7), pp.645~649 (2016)
- Megari K, "Quality of life in chronic disease patients", Health Psychol Res, 1(3), pp.e27~ (2013)
- Health Insurance Review and Assessment Service, "Guidelines for economic evaluation of pharmaceuticals. 2nd ed", Health Insurance Review and Assessment Service, 10~ (2011)
- Janssen MF, "Comparing the standard EQ-5D three-level system with a five-level version", Value Health, 11(2), pp.275~284 (2008)
- 이우제, "Health-Related Quality of Life Using the EuroQol 5D Questionnaire in Korean Patients with Type 2 Diabetes", Journal of Korean Medical Science, 27(3), pp.255~260 (2012), 대한의학회
- Kim SH, "Validity and reliability of EQ-5D-3L for breast cancer patients in Korea", Health Qual Life Outcomes, 13, pp.203~ (2015)
- Kim SH, "The EQ-5D-5L valuation study in Korea", Qual Life Res, 25(7), pp.1845~1852 (2016)
- Kim SH, "Validity and reliability of the EQ-5D for cancer patients in Korea", Support Care Cancer, 20(12), pp.3155~3160 (2012)
- Kim SH, "Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea", Qual Life Res, 21(6), pp.1065~1073 (2012)
- Kim SK, "Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke", Health Qual Life Outcomes, 13, pp.32~ (2015)
- Kim TH, "Psychometric properties of the EQ-5D-5L in the general population of South Korea", Qual Life Res, 22(8), pp.2245~2253 (2013)
- Lee YK, "South Korean time trade-offvalues for EQ-5D health states : modeling with observed values for 101 health states", Value Health, 12(8), pp.1187~1193 (2009)
- Ock M, "Measuring health related quality of life using EQ-5D in South Korea", J Health Tech Assess, 1(1), pp.103~111 (2013)
- Seon Ha Kim, "Psychometric Properties of the Korean Short Form-36 Health Survey Version 2 for Assessing the General Population", Asian Nursing Research, 7(2), pp.61~66 (2013), 한국간호과학회
- Development of the measurement tool for health related quality of life in the Korea National Health and Nutrition Examination Survey, "Jo MW", Korea Centers for Disease Control and Prevention, 97~ (2014)
- Lee HJ, "Development and psychometric evaluation of measurement instrument for Korean health-related quality of life", Public Health Wkly Rep, 9(24), pp.447~454 (2016)
- 이은현, "국내 연구에서 당뇨병 환자 건강관련 삶의 질 측정에 관한 모니터링", Journal of Korean Academy of Nursing, 41(4), pp.558~567 (2011), 한국간호과학회
- El Achhab Y, "Disease-specific health-related quality of life instruments among adults diabetic : a systematic review", Diabetes Res Clin Pract, 80(2), pp.171~184 (2008)
- Hu J, "Psychometric properties of the Chinese version of the SF-36 in older adults with diabetes in Beijing, China", Diabetes Res Clin Pract, 88(3), pp.273~281 (2010)
- Valuation of Korean health-related quality of life instrument with 8 items (HINT-8), "Jo MW", Korean Centers for Disease Control and Prevention, 28~ (2017)
- van Reenen M, "EQ-5D-5L user guide: basic information on how to use the EQ-5D-5L instrument", EuroQol Research Foundation, 9~ (2015)
- Maruish ME, "User’s manual for the SF-36v2 health survey", Quality Metric Incorporated, 198~ (2011)
- Brazier JE, "The estimation of a preference-based measure of health from the SF-12", Med Care, 42(9), pp.851~859 (2004)
- Brazier J, "The estimation of a preference-based measure of health from the SF-36", J Health Econ, 21(2), pp.271~292 (2002)
- Fayers PM, "Assessing quality of life in clinical trials: methods and practice", pp.421~ (2005), Oxford University Press
- Viera AJ, "Understanding interobserver agreement : the kappa statistic", Fam Med, 37(5), pp.360~363 (2005)
- Koo TK, "A guideline of selecting and reporting intraclass correlation coefficients for reliability research", J Chiropr Med, 15(2), pp.155~163 (2016)
- Streiner DL, "Health measurement scales: a practical guide to their development and use", pp.177~ (2014), Oxford University Press
- Landis JR, "The measurement of observer agreement for categorical data", Biometrics, 33(1), pp.159~174 (1977)
- Janssen MF, "Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups : a multi-country study", Qual Life Res, 22(7), pp.1717~1727 (2013)
- Janssen MF, "Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries", Pharmacoeconomics, 36(6), pp.675~697 (2018)
- Mulhern B, "The construct validity and responsiveness of the EQ-5D, SF-6D and diabetes health profile-18 in type 2 diabetes", Health Qual Life Outcomes, 12, pp.42~ (2014)
- Kiadaliri AA, "Does the choice of EQ-5D tariffmatter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients", Health Qual Life Outcomes, 13, pp.145~ (2015)
- Koh D, "Validation of Brunei’s Malay EQ-5D questionnaire in patients with type 2 diabetes", PLoS One, 11(11), pp.e0165555~ (2016)
